Mutations at codons 54 and 82 of HIV protease predict virological response of HIV-infected children on salvage lopinavir/ritonavir therapy | Zendy

José Luis Jimeénez | Zendy; Salvador Resino | Zendy; Alberto Martinez-Colom | Zendy; José M. Bellón | Zendy; María Ángeles MuñozFernández | Zendy

Open Access

Mutations at codons 54 and 82 of HIV protease predict virological response of HIV-infected children on salvage lopinavir/ritonavir therapy

Author(s) -

José Luis Jimeénez,

Salvador Resino,

Alberto Martinez-Colom,

José M. Bellón,

María Ángeles MuñozFernández

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki356

Subject(s) - lopinavir , lopinavir/ritonavir , ritonavir , virology , salvage therapy , medicine , human immunodeficiency virus (hiv) , protease inhibitor (pharmacology) , lentivirus , protease , viral load , antiretroviral therapy , biology , viral disease , chemotherapy , enzyme , biochemistry

Lopinavir/ritonavir is a protease inhibitor (PI) that has shown great effectiveness as salvage therapy in PI-experienced HIV-infected children.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research